Angiotensin 1/2 (5-7): Precision Peptide for RAS & Hypertension Research

Executive Summary: Angiotensin 1/2 (5-7) is a biologically active oligopeptide with the sequence H2N-Ile-His-Pro-OH and a molecular weight of 365.43 g/mol. It is a potent vasoconstrictor, directly involved in blood pressure regulation within the renin-angiotensin system (RAS) (Oliveira et al., 2025). High-purity Angiotensin 1/2 (5-7) from APExBIO (SKU: A1049) is supplied as a solid, with confirmed solubility ≥36.5 mg/mL in DMSO, ≥50 mg/mL in ethanol and water, and is validated for bench research. Peer-reviewed evidence demonstrates its ability to enhance SARS-CoV-2 spike protein binding, highlighting its translational value in viral pathogenesis studies (DOI). Quality control includes HPLC purity (98.36%) and mass spectrometry confirmation.

Biological Rationale

Angiotensin 1/2 (5-7) is a tripeptide derived from the proteolytic cleavage of angiotensinogen, a liver-produced serum globulin, via the renin-angiotensin pathway (Oliveira et al., 2025). As a component of the RAS, it mediates critical cardiovascular and renal functions through vasoconstriction and regulation of fluid balance. The peptide sequence, H2N-Ile-His-Pro-OH, corresponds to residues 5–7 of the angiotensin I/II peptides, and is biologically active, unlike its precursor angiotensin I, which is inactive (internal: Mechanistic Insight). Angiotensin 1/2 (5-7) acts as a dipsogen, stimulating thirst, and plays a role in pathophysiological conditions such as hypertension. Its activity is mediated via interactions with G protein-coupled receptors (GPCRs), notably the angiotensin II receptor subtypes AT1R and AT2R. These effects are central to both homeostatic and disease processes involving blood pressure and electrolyte regulation.

This article extends the detailed mechanistic review provided in 'Mechanistic Insight, Translational Potential' by focusing on practical workflow integration, solubility parameters, and benchmarked evidence in disease models.

Mechanism of Action of Angiotensin 1/2 (5-7)

Angiotensin 1/2 (5-7) exerts its physiological effects through potent vasoconstriction, leading to increased arterial blood pressure (Oliveira et al., 2025). The peptide binds specifically to AT1R and possibly AT2R receptors, triggering intracellular signaling cascades that result in smooth muscle contraction and vascular resistance (internal: Precision Peptide for Hypertension). It also stimulates dipsogenic responses, promoting fluid intake. In the context of viral pathogenesis, Angiotensin 1/2 (5-7) and related angiotensin peptides have been shown to enhance the binding of the SARS-CoV-2 spike protein to host receptors such as AXL, potentially influencing infection susceptibility and progression (DOI). The mechanism involves altered receptor affinity and may be modulated by post-translational modifications to peptide residues, as demonstrated by phosphorylation studies.

Evidence & Benchmarks

• Angiotensin 1/2 (5-7) (H2N-Ile-His-Pro-OH) is a cleavage product of angiotensin II, with a molecular weight of 365.43 g/mol and formula C17H27N5O4 (APExBIO).
• It is soluble at concentrations ≥36.5 mg/mL in DMSO, ≥50 mg/mL in ethanol, and ≥50 mg/mL in water, supporting diverse experimental workflows (APExBIO).
• Short C- or N-terminal angiotensin peptides, including angiotensin (5–7), enhance SARS-CoV-2 spike protein binding to AXL, increasing binding up to 2.7-fold relative to controls (Oliveira et al., 2025, DOI).
• Validated purity (98.36% by HPLC) and mass spectrometry confirmation ensure experimental reproducibility (APExBIO).
• The peptide’s vasoconstrictor effect is consistent with its established role in RAS-mediated blood pressure regulation (Oliveira et al., 2025, DOI).
• Distinct from longer angiotensin I (1–10), angiotensin 1/2 (5-7) is biologically active and elicits measurable physiological responses (internal: Reliable Peptide for RAS).

This article clarifies solubility and workflow benchmarks, complementing the scenario-driven protocols in 'Reliable Peptide for RAS and Cytot.'

Applications, Limits & Misconceptions

Angiotensin 1/2 (5-7) is utilized in research on hypertension, cardiovascular regulation, renal physiology, and viral pathogenesis (notably SARS-CoV-2) (Oliveira et al., 2025). Its reliable solubility profile allows application in in vitro, ex vivo, and in vivo models. Benchmarking in COVID-19 research has further expanded its relevance, demonstrating peptide-mediated modulation of viral receptor binding. However, its use is confined to research applications and is not approved for diagnostic or therapeutic use in humans or animals. Misconceptions may arise from conflation with other angiotensin fragments or improper handling, which can reduce stability and reproducibility.

Common Pitfalls or Misconceptions

• Angiotensin 1/2 (5-7) is not biologically equivalent to angiotensin I (1–10) or angiotensin II (1–8); functional outcomes differ significantly.
• Improper storage above -20°C or repeated freeze-thaw cycles degrade peptide integrity and activity.
• Long-term storage of peptide solutions (in DMSO, ethanol, or water) is not recommended; immediate use after dissolution is advised.
• It is not approved for therapeutic or diagnostic use; research-only application is mandated.
• Confusion with angiotensin (2–7), (1–7), or (3–8) can lead to erroneous attribution of biological effects.

This article updates and clarifies correct application boundaries, extending the translational context of 'Empowering Hypertension and Viral Pathogenesis Workflows'.

Workflow Integration & Parameters

Angiotensin 1/2 (5-7) is supplied as a solid, with recommended storage at -20°C. Solutions should be freshly prepared at concentrations ≥36.5 mg/mL in DMSO, or ≥50 mg/mL in ethanol or water, depending on experimental requirements (APExBIO). All solutions should be used promptly to maintain stability and bioactivity. Quality control includes HPLC (98.36% purity) and confirmation by mass spectrometry. Shipping is performed on blue ice to preserve product integrity during transit. Bench researchers should avoid extended exposure to ambient temperatures and repeated freeze-thaw cycles. For RAS and hypertension studies, dosing and timing parameters should be standardized based on model organism or assay type, referencing recent literature protocols.

For additional protocol strategies and troubleshooting, readers should consult 'Reliable Peptide for RAS and Cytot.', which provides scenario-driven guidance and data interpretation.

Conclusion & Outlook

Angiotensin 1/2 (5-7) (H2N-Ile-His-Pro-OH) represents a mechanistically validated, high-purity peptide tool for RAS and hypertension research. Its reliable solubility and confirmed vasoconstrictor activity enable robust, reproducible experimental outcomes. Recent evidence of its role in enhancing SARS-CoV-2 spike–host receptor interactions further expands its translational value (DOI). APExBIO’s A1049 formulation provides researchers with a standardized reagent for advanced cardiovascular and virology workflows. Continued benchmarking and mechanistic studies will refine its use in emerging research domains.

For detailed product specifications and ordering, visit the Angiotensin 1/2 (5-7) product page (A1049).